EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

The Pharmacogenomics Journal

ISSN 1470-269X · Springer Science and Business Media LLC

Latest articles

  1. Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approach

    Siana Nkya, Collin Nzunda, Emmanuel Saukiwa, Frida Kaywanga, Eliud Buchard, David Solomon, Heavenlight Christopher, Doreen Ngowi, Julieth Johansen, Florence Urio, Josephine Mgaya, Christina Kindole, Mbonea Yonazi, Salman Karim, Mohamed Zahir Alimohamed, Raphael Z. Sangeda, Clara Chamba, Collet Dandara, Enrico Novelli, Emile R. Chimusa, Julie Makani

    Published: 2025-06DOI: 10.1038/s41397-025-00372-3

  2. Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients

    Moataz E. Mohamed, Bin Guo, Baolin Wu, David P. Schladt, Amutha Muthusamy, Weihua Guan, Juan E. Abrahante, Guillaume Onyeaghala, Abdelrahman Saqr, Nathan Pankratz, Gaurav Agarwal, Roslyn B. Mannon, Arthur J. Matas, William S. Oetting, Rory P. Remmel, Ajay K. Israni, Pamala A. Jacobson, Michael Cecka, John E. Connett, Fernando G. Cosio, Robert S. Gaston, Sita Gourishankar, Joseph P. Grande, Lawrence G. Hunsicker, David N. Rush, Bertram L. Kasiske, Casey R. Dorr

    Published: 2024-10DOI: 10.1038/s41397-024-00349-8

Volumes

2026 · 422025 · 342024 · 392023 · 292022 · 402021 · 722020 · 892019 · 602018 · 932017 · 832016 · 782015 · 732014 · 792013 · 752012 · 692011 · 492010 · 552009 · 512008 · 502007 · 502006 · 592005 · 552004 · 662003 · 622002 · 712001 · 62

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.